“COVID phobia” has increased the novel coronavirus’ collateral damage by stopping high-risk patients from seeking necessary care.

With the world’s attention on new and re-emerging outbreaks of COVID-19, advocates are working towards policies that ensure care for overshadowed patient groups.

As the COVID-19 pandemic drives a global telemedicine revolution, one Latin American initiative is proving the value of remote care.

As policymakers grapple with whether, or when, to end coronavirus lockdowns, patient advocacy organisations continue to urge policies that protect people with chronic disease.

As the COVID-19 crisis grows, policymakers may be overlooking a vulnerable population: patients living with rheumatic and musculoskeletal diseases like rheumatoid arthritis.

A new report spotlights the need for patient-centred neurological care across the globe.

This month’s JAMA Cardiology features an international call to action from the global community impacted by familial hypercholesterolemia, or FH.

Earlier, more aggressive cholesterol management could reap important cardiovascular benefits, a recent study reports.

Not all patients have enough information to protect themselves from preventable heart attacks and strokes, a newly released questionnaire of European patients confirms.

Patient advocacy organisations across Europe are banding together to improve cardiovascular health.